Profile data is unavailable for this security.
About the company
Exact Therapeutics AS is a Norway-based clinical-stage biopharmaceutical company, which develops ultrasound-mediated technology platform for targeted therapeutic enhancement Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within cancer (chemotherapy, immunotherapy), infectious diseases, and neurological conditions. The Company's purpose is to extend and enrich patient lives through targeted therapeutic enhancement. It is done through harnessing the power of ultrasound in combination with ACT formulation.
- Revenue in NOK (TTM)0.00
- Net income in NOK-57.98m
- Incorporated2012
- Employees8.00
- LocationExact Therapeutics ASOstre Aker vei 19OSLO 0581NorwayNOR
- Websitehttps://www.exact-tx.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lifecare AS | 10.28m | -17.86m | 289.36m | -- | -- | 12.91 | -- | 28.15 | -0.1652 | -0.1652 | 0.0959 | 0.1902 | 0.4309 | -- | 2.26 | -- | -74.86 | -- | -93.53 | -- | -- | -- | -173.74 | -- | -- | -- | 0.2527 | -- | -70.34 | -- | -508.85 | -- | -- | -- |
| Opticept Technologies AB | 8.69m | -75.40m | 301.56m | -- | -- | 0.637 | -- | 34.71 | -3.59 | -3.59 | 0.4126 | 16.55 | 0.0212 | 0.4034 | 1.13 | -- | -18.51 | -48.78 | -20.04 | -52.07 | 29.73 | 131.87 | -874.93 | -840.77 | 0.9775 | -71.81 | 0.0701 | -- | 1,532.35 | -- | -396.50 | -- | 54.76 | -- |
| Abliva AB | 75.70k | -100.19m | 309.23m | 8.00 | -- | 1.77 | -- | 4,084.80 | -0.2269 | -0.2269 | 0.0002 | 0.1721 | 0.0005 | -- | 0.0017 | 9,875.00 | -68.89 | -67.30 | -80.31 | -79.05 | -- | -- | -132,358.20 | -76,095.50 | -- | -35.46 | 0.00 | -- | -30.09 | 60.91 | -105.86 | -- | -43.06 | -- |
| Initiator Pharma A/S | 0.00 | -58.91m | 309.74m | -- | -- | 5.73 | -- | -- | -1.29 | -1.29 | 0.00 | 1.08 | 0.00 | -- | -- | -- | -74.43 | -70.46 | -78.10 | -80.40 | -- | -- | -- | -- | -- | -- | 0.2643 | -- | -- | -- | -142.20 | -- | -- | -- |
| Lytix Biopharma AS | 1.41m | -43.21m | 320.55m | -- | -- | 1.89 | -- | 227.50 | -1.12 | -1.12 | 0.0364 | 4.23 | 0.0072 | -- | 0.2655 | -- | -22.07 | -- | -23.41 | -- | -- | -- | -3,066.50 | -- | -- | -- | 0.00 | -- | 466.67 | -- | -14.16 | -- | -- | -- |
| Biovica International AB | 2.78m | -74.40m | 335.87m | 27.00 | -- | 3.13 | -- | 120.78 | -2.69 | -2.69 | 0.1007 | 2.84 | 0.0213 | -1.82 | 6.01 | 116,080.00 | -56.94 | -30.85 | -62.19 | -33.47 | 179.12 | 332.81 | -2,675.53 | -1,470.09 | 3.20 | -423.61 | 0.1315 | -- | -1.54 | 26.47 | -51.97 | -- | -- | -- |
| Vo2 Cap Holding AB (publ) | 398.49m | 5.73m | 341.33m | -- | 56.71 | 1.89 | 18.39 | 0.8566 | 0.1218 | 0.1218 | 8.65 | 3.66 | 1.47 | -- | 8.15 | -- | 2.12 | -31.87 | 3.07 | -57.95 | 22.34 | 26.64 | 1.44 | -19.29 | -- | 5.20 | 0.1549 | -- | 46,310.78 | 185.46 | -246.86 | -- | -- | -- |
| Cereno Scientific AB | 0.00 | -22.28m | 355.80m | -- | -- | 1.35 | -- | -- | -0.2209 | -0.2209 | 0.00 | 2.00 | 0.00 | -- | -- | -- | -10.95 | -18.58 | -11.93 | -20.82 | -- | -- | -- | -- | -- | -27.72 | 0.025 | -- | -- | -- | -1.48 | -- | 54.51 | -- |
| Exact Therapeutics AS | 0.00 | -57.98m | 389.96m | 8.00 | -- | 2.87 | -- | -- | -2.71 | -2.71 | 0.00 | 4.52 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0137 | -- | -- | -- | -123.18 | -- | -- | -- |
| Alligator Bioscience AB | 20.01m | -169.56m | 408.39m | 55.00 | -- | 3.01 | -- | 20.41 | -1.11 | -1.11 | 0.1129 | 0.6421 | 0.124 | -- | 2.06 | 453,978.30 | -105.05 | -33.26 | -145.40 | -36.20 | -- | -- | -847.30 | -672.07 | -- | -- | 0.1175 | -- | 197.40 | -25.98 | 1.09 | -- | -58.36 | -- |
| Herantis Pharma Oyj | 0.00 | -114.17m | 451.42m | -- | -- | 21.59 | -- | -- | -0.8301 | -0.8301 | 0.00 | 0.1135 | 0.00 | -- | -- | -- | -110.52 | -65.71 | -198.51 | -79.09 | -- | -- | -- | -- | -- | -6.65 | 0.7896 | -- | -- | -- | -39.49 | -- | -- | -- |
| ExpreS2ion Biotech Holding AB | 8.62m | -80.87m | 457.68m | 26.00 | -- | 3.21 | -- | 53.09 | -2.39 | -2.39 | 0.2557 | 3.96 | 0.0545 | -- | 3.28 | 391,173.90 | -51.16 | -45.28 | -55.81 | -54.17 | -104.61 | 58.57 | -938.00 | -194.44 | -- | -- | 0.0272 | -- | -10.04 | -- | -38.51 | -- | -- | -- |
| Ascelia Pharma AB | 0.00 | -108.20m | 461.37m | 21.00 | -- | 2.09 | -- | -- | -3.30 | -3.30 | 0.00 | 6.84 | 0.00 | -- | -- | 0.00 | -36.47 | -- | -39.44 | -- | -- | -- | -- | -- | -- | -- | 0.0031 | -- | -- | -- | -27.57 | -- | -- | -- |
| Nightingale Health Oyj | 25.20m | -175.30m | 462.54m | 64.00 | -- | 0.588 | -- | 18.36 | -0.2641 | -0.2641 | 0.038 | 1.85 | 0.0176 | 1.66 | 2.22 | 36,140.63 | -12.23 | -13.89 | -13.06 | -15.61 | 55.17 | 84.27 | -695.68 | -354.56 | 12.21 | -5.27 | 0.0661 | -- | 0.3471 | 8.42 | -65.46 | -- | -- | -- |
| Immunovia AB (publ) | 908.44k | -141.73m | 481.46m | 64.00 | -- | 1.70 | -- | 529.98 | -6.54 | -6.54 | 0.0419 | 13.09 | 0.0021 | 58.92 | 10.53 | 14,584.62 | -32.41 | -24.95 | -35.03 | -26.29 | -7,933.23 | -10,942.72 | -15,601.05 | -26,830.18 | 5.66 | -- | 0.1186 | -- | 133.15 | 36.63 | -6.80 | -- | -4.73 | -- |
| Mendus AB (publ) | 1.72m | -122.99m | 491.08m | 31.00 | -- | 0.9132 | -- | 285.65 | -0.6472 | -0.6472 | 0.0091 | 2.81 | 0.0026 | -- | 0.0945 | 59,800.00 | -18.38 | -23.81 | -19.01 | -26.35 | -- | -- | -7,154.29 | -- | -- | -29.22 | 0.0451 | -- | -- | -- | -49.48 | -- | -- | -- |
Data as of Feb 01 2023. Currency figures normalised to Exact Therapeutics AS's reporting currency: Norwegian Krone NOK
6.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nordea Investment Management AB (Norway)as of 29 Jul 2022 | 1.24m | 4.15% |
| Danske Invest Asset Management ASas of 30 Dec 2022 | 590.75k | 1.97% |
Data from 30 Nov 2022 - 31 Dec 2022Source: FactSet Research Systems Inc.
